Crispr Therapeutics shares owned by Brave Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Brave Asset Management
from 13F filings
Historical chart of Brave Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Brave Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Brave Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $624k | 9.1k | 68.16 |
2023-12-31 | $773k | 12k | 62.60 |
2023-09-30 | $303k | 6.7k | 45.39 |
2023-06-30 | $374k | 6.7k | 56.14 |
2023-03-31 | $346k | 7.6k | 45.23 |
2022-03-31 | $220k | 3.5k | 62.86 |
2021-12-31 | $265k | 3.5k | 75.71 |
2021-09-30 | $280k | 2.5k | 112.00 |